Michal Kýr

517 total citations
29 papers, 284 citations indexed

About

Michal Kýr is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Michal Kýr has authored 29 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Michal Kýr's work include Sepsis Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Michal Kýr is often cited by papers focused on Sepsis Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (3 papers). Michal Kýr collaborates with scholars based in Czechia, United States and Slovakia. Michal Kýr's co-authors include Jaroslav Štěrba, Michal Fedora, Peter Múdrý, Jiří Žůrek, Martin Vavřina, Renata Veselská, Karel Zitterbart, Iva Staniczková Zambo, Marta Ježová and Jaroslav Michálek and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care and Cancers.

In The Last Decade

Michal Kýr

28 papers receiving 281 citations

Peers

Countries citing papers authored by Michal Kýr

Since Specialization

Citations

This map shows the geographic impact of Michal Kýr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Kýr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Kýr more than expected).

Fields of papers citing papers by Michal Kýr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Kýr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Kýr. The network helps show where Michal Kýr may publish in the future.

Co-authorship network of co-authors of Michal Kýr

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Kýr. A scholar is included among the top collaborators of Michal Kýr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Kýr. Michal Kýr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing 2022 ·JCO Precision Oncology ·Petra Pokorná, Giannoula Klement, (unknown), Veronika Kanderová, Marta Ježová, Kristýna Nosková, Peter Múdrý, Michal Kýr, (unknown), Viera Bajčiová, Zdenka Křenová, Hana Pálová, Dalibor Valík, Lenka Zdražilová Dubská, Ondřej Slabý, Jaroslav Štěrba	2
2	Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis 2021 ·Journal of bone oncology ·Peter Múdrý, Michal Kýr, (unknown), (unknown), Iva Staniczková Zambo, Marta Ježová, (unknown), Jaroslav Štěrba	20
3	Granulation tissue enriched by aspirin and omega-3 fatty acids in healing experimental periodontal lesion 2020 ·Biomedical Papers ·(unknown), (unknown), (unknown), Martin Faldyna, Markéta Hermanová, Michal Kýr, (unknown), Lýdie Izakovičová Hollá	1
4	Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy 2019 ·Frontiers in Oncology ·Renata Veselská, Marta Ježová, Michal Kýr, Pavel Mazánek, Petr Chlapek, (unknown), Jaroslav Štěrba	7
5	Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology 2019 ·Frontiers in Oncology ·Jakub Neradil, Michal Kýr, (unknown), Leoš Křen, (unknown), J. Škoda, Jaroslav Štěrba, Renata Veselská	9
6	Clinical and laboratory characteristics of enteroviral meningitis in children, including qRT-PCR and sequencing analysis 2019 ·Biomedical Papers ·(unknown), (unknown), Petra Rainetová, Martin Musílek, (unknown), (unknown), (unknown), (unknown), (unknown), Jana Bednářová, Michal Kýr	4
7	Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario 2019 ·Frontiers in Oncology ·Michal Kýr, (unknown), (unknown), (unknown), Jakub Neradil, (unknown), (unknown), Marta Ježová, Renata Veselská, Giannoula Klement, Dalibor Valík, Jaroslav Štěrba	1
8	Early Dynamics of Interleukin-6 in Cerebrospinal Fluid after Aneurysmal Subarachnoid Hemorrhage 2017 ·Journal of Neurological Surgery Part A Central European Neurosurgery ·Kamil Ďuriš, (unknown), Václav Vybíhal, (unknown), (unknown), Michal Kýr, Anna Vašků, Martin Smrčka	17
9	Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours—a single institution pilot study 2016 ·Tumor Biology ·Julie Bienertová Vašků, (unknown), Filip Zlámal, Josef Tomandl, Michal Kýr, Zbyněk Šplíchal, Jaroslav Štěrba	10
10	Trefoil factor 3 as a marker of intestinal cell damage during sepsis 2015 ·SHILAP Revista de lepidopterología ·Jiří Žůrek, Michal Kýr, Martin Vavřina, Michal Fedora	9
11	Pancreatic stone protein – A possible biomarker of multiorgan failure and mortality in children sepsis 2014 ·Cytokine ·Jiří Žůrek, Michal Kýr, Martin Vavřina, Michal Fedora	16
12	Trefoil factor 2 expression and its significance as a predictor of severity of sepsis in children 2013 ·Peptides ·Jiří Žůrek, Michal Kýr, Martin Vavřina, Michal Fedora	2
13	Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience 2012 ·Oncology ·(unknown), Nicolás André, (unknown), Michal Kýr, Viera Bajčiová, Peter Múdrý, Lenka Zdražilová Dubská, Regina Demlová, Zdeněk Pavelka, Karel Zitterbart, (unknown), (unknown), (unknown), Pavel Mazánek, Tomáš Kepák, (unknown), (unknown), Dalibor Valík, Jaroslav Štěrba	56
14	Apolipoprotein E ε4-Positive Multiple Sclerosis Patients Develop More Gray-Matter and Whole-Brain Atrophy: a 15-Year Disease History Model Based on a 4-Year Longitudinal Study 2010 ·Folia Biologica ·Dana Horáková, Michal Kýr, Eva Havrdová, Ondřej Doležal, Petra Lelková, Lenka Pospíšilová, Niels Bergsland, Michael G. Dwyer, Jennifer Cox, Sara Hussein, Zdeněk Seidl, Manuela Vaněčková, Jan Krásenský, Robert Zivadinov	7
15	Cytokine response in severe sepsis – Predicting and modelling the course of illness 2010 ·International Journal of Infectious Diseases ·Jan Maláska, Milan Kratochvíl, Michal Kýr, Petr Jabandžiev, (unknown), (unknown), Michal Fedora, Vladimír Šrámek, Jaroslav Michálek, (unknown)	3
16	Clinicopathological Correlations of Cyclooxygenase-2, MDM2, and p53 Expressions in Surgically Resectable Pancreatic Invasive Ductal Adenocarcinoma 2009 ·Pancreas ·Markéta Hermanová, Petr Karásek, Rudolf Nenutil, Michal Kýr, Jiří Tomášek, (unknown), Petr Dítě	14
17	Renální toxicita vysokých dávek ifosfamidu u pacientů s Ewingovým sarkomem/PNET 2009 ·(unknown), Michal Kýr, Peter Múdrý, (unknown), Tomáš Kepák, Jaroslav Štěrba	1
18	Modeling effect of the septic condition and trauma on C-reactive protein levels in children with sepsis: a retrospective study 2007 ·Critical Care ·Michal Kýr, Michal Fedora, Lubomı́r Elbl, (unknown), Jaroslav Michálek	10
19	Immune Regulatory T Cells in Siblings of Children Suffering from Type 1 Diabetes Mellitus 2006 ·Scandinavian Journal of Immunology ·Jaroslav Michálek, (unknown), (unknown), Michal Kýr, (unknown), Stanislava Koloušková, Maria Faresjö, Kateřina Štechová	14
20	Morphological evidence of collateral sprouting of intact afferent and motor axons of the rat ulnar nerve demonstrated by one type of tracer molecule 2004 ·Annals of Anatomy - Anatomischer Anzeiger ·(unknown), Michal Kýr, Pavel Haninec, (unknown), Petr Dubový	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact